Beta-adrenergic blocking agents in heart failure
Cardiac dysfunction in heart failure is widely recognized as a progressive process, regardless of the clinical signs and symptoms. An increase in cardiac sympathetic drive is one of the earliest neurohormonal responses occurring in patients with heart failure and may be one of the major causes of th...
Main Authors: | Michel Batlouni, Denilson Campos de Albuquerque |
---|---|
Format: | Article |
Language: | English |
Published: |
Sociedade Brasileira de Cardiologia (SBC)
2000-10-01
|
Series: | Arquivos Brasileiros de Cardiologia |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2000001000009 |
Similar Items
-
Beta-adrenergic blocking agent in cardiovascular disease: focus on metoprolol
by: G A Baryshnikov, et al.
Published: (2014-09-01) -
Adrenergic blocking agents in glaucoma
by: Srivastava S
Published: (1954-01-01) -
Mechanism of heart failure resulting from chronic beta-adrenergic stimulation
by: Carr, C, et al.
Published: (2004) -
Unraveling the relationships between alpha- and beta-adrenergic modulation and the risk of heart failure
by: Claire Baudier, et al.
Published: (2023-10-01) -
Beta-adrenergic reactivity of erythrocytes and the progression of heart failure in patients after myocardial infarction
by: A. A. Garganeeva, et al.
Published: (2020-02-01)